RMTI


Company Update (NASDAQ:RMTI): Rockwell Medical Inc to Present at Stifel 2015 Healthcare Conference

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Company Update (NASDAQ:RMTI): Rockwell Medical Inc Reports Third Quarter 2015 Results

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Announces Presentation Schedule for Triferic Clinical Posters at American Society of Nephrology (ASN) Meeting November 2015

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Oppenheimer Weighs In on Two Small Cap Healthcare Stocks: OvaScience Inc (OVAS), Rockwell Medical Inc (RMTI)

Oppenheimer analysts are weighing in on the Cambridge-based fertility company OvaScience Inc (NASDAQ:OVAS) and biopharmaceutical company Rockwell Medical Inc (NASDAQ:RMTI), with positive ratings. OvaScience Inc In …

Stock Update (NASDAQ:RMTI): Rockwell Medical, Inc. Introduces New Video Demonstrating Triferic(R) Mode-of-Action

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services …

Company Update (NASDAQ:RMTI): Rockwell Medical Inc Launches New Triferic(TM) Website

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services …

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Announces the U.S. Commercial Launch of Triferic (TM)

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Oppenheimer Reiterates Outperform on Rockwell Medical Inc (RMTI) Following Positive Feedback on Triferic

In a research report released on Friday, Oppenheimer analyst Ling Wang reiterated an Outperform rating on shares of Rockwell Medical Inc (NASDAQ:RMTI) with a …

Insider Trading News: Skyworks Solutions Inc (SWKS), Palo Alto Networks Inc (PANW), Celldex Therapeutics, Inc. (CLDX), Rockwell Medical Inc (RMTI)

Recently, various executives have taken part in insider trading activity for the stocks of Skyworks Solutions Inc (NASDAQ:SWKS), Palo Alto Networks Inc (NYSE:PANW), Celldex Therapeutics, …

Brean Capital Remains Bearish on Rockwell Medical Inc Following 2Q:15 Results

Brean Capital’s healthcare analyst Jonathan Aschoff  weighed in with a negative view on Rockwell Medical Inc (NASDAQ:RMTI), reiterating a Sell rating on the stock, with a $4.00 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts